These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 9543135)
1. Pharmacokinetics and pharmacodynamics of growth hormone-releasing peptide-2: a phase I study in children. Pihoker C; Kearns GL; French D; Bowers CY J Clin Endocrinol Metab; 1998 Apr; 83(4):1168-72. PubMed ID: 9543135 [TBL] [Abstract][Full Text] [Related]
2. Tripartite neuroendocrine activation of the human growth hormone (GH) axis in women by continuous 24-hour GH-releasing peptide infusion: pulsatile, entropic, and nyctohemeral mechanisms. Shah N; Evans WS; Bowers CY; Veldhuis JD J Clin Endocrinol Metab; 1999 Jun; 84(6):2140-50. PubMed ID: 10372723 [TBL] [Abstract][Full Text] [Related]
3. Growth hormone-releasing effect of oral growth hormone-releasing peptide 6 (GHRP-6) administration in children with short stature. Bellone J; Ghizzoni L; Aimaretti G; Volta C; Boghen MF; Bernasconi S; Ghigo E Eur J Endocrinol; 1995 Oct; 133(4):425-9. PubMed ID: 7581965 [TBL] [Abstract][Full Text] [Related]
4. Effects of a prolonged growth hormone (GH)-releasing peptide infusion on pulsatile GH secretion in normal men. Jaffe CA; Ho PJ; Demott-Friberg R; Bowers CY; Barkan AL J Clin Endocrinol Metab; 1993 Dec; 77(6):1641-7. PubMed ID: 7903313 [TBL] [Abstract][Full Text] [Related]
5. Treatment effects of intranasal growth hormone releasing peptide-2 in children with short stature. Pihoker C; Badger TM; Reynolds GA; Bowers CY J Endocrinol; 1997 Oct; 155(1):79-86. PubMed ID: 9390009 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic studies with intravenous and intranasal growth hormone-releasing peptide-2 in children of short stature. Pihoker C; Middleton R; Reynolds GA; Bowers CY; Badger TM J Clin Endocrinol Metab; 1995 Oct; 80(10):2987-92. PubMed ID: 7559885 [TBL] [Abstract][Full Text] [Related]
7. The growth hormone-releasing activity of a synthetic hexapeptide in normal men and short statured children after oral administration. Bowers CY; Alster DK; Frentz JM J Clin Endocrinol Metab; 1992 Feb; 74(2):292-8. PubMed ID: 1730807 [TBL] [Abstract][Full Text] [Related]
8. Single and multiple dose pharmacokinetics of methionyl growth hormone in children with idiopathic growth hormone deficiency. Kearns GL; Kemp SF; Frindik JP J Clin Endocrinol Metab; 1991 May; 72(5):1148-56. PubMed ID: 2022713 [TBL] [Abstract][Full Text] [Related]
9. Effect of growth hormone (GH)-releasing hormone (GHRH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man. Peñalva A; Carballo A; Pombo M; Casanueva FF; Dieguez C J Clin Endocrinol Metab; 1993 Jan; 76(1):168-71. PubMed ID: 8421084 [TBL] [Abstract][Full Text] [Related]
11. The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion. Van den Berghe G; de Zegher F; Veldhuis JD; Wouters P; Awouters M; Verbruggen W; Schetz M; Verwaest C; Lauwers P; Bouillon R; Bowers CY J Clin Endocrinol Metab; 1997 Feb; 82(2):590-9. PubMed ID: 9024260 [TBL] [Abstract][Full Text] [Related]
12. Twenty-four-hour growth hormone (GH)-releasing peptide (GHRP) infusion enhances pulsatile GH secretion and specifically attenuates the response to a subsequent GHRP bolus. Huhn WC; Hartman ML; Pezzoli SS; Thorner MO J Clin Endocrinol Metab; 1993 May; 76(5):1202-8. PubMed ID: 8496311 [TBL] [Abstract][Full Text] [Related]
13. Effects of repeated doses and continuous infusions of the growth hormone-releasing peptide hexarelin in conscious male rats. Conley LK; Gaillard RC; Giustina A; Brogan RS; Wehrenberg WB J Endocrinol; 1998 Sep; 158(3):367-75. PubMed ID: 9846166 [TBL] [Abstract][Full Text] [Related]
14. Influence of sex, age and adrenergic pathways on the growth hormone response to GHRP-6. Peñalva A; Pombo M; Carballo A; Barreiro J; Casanueva FF; Dieguez C Clin Endocrinol (Oxf); 1993 Jan; 38(1):87-91. PubMed ID: 8435889 [TBL] [Abstract][Full Text] [Related]
15. The effects of growth hormone-releasing peptide-2 (GHRP-2) on the release of growth hormone and growth performance in swine. Phung LT; Inoue H; Nou V; Lee HG; Vega RA; Matsunaga N; Hidaka S; Kuwayama H; Hidari H Domest Anim Endocrinol; 2000 Apr; 18(3):279-91. PubMed ID: 10793268 [TBL] [Abstract][Full Text] [Related]
16. Acute growth hormone (GH) response to GH-releasing hexapeptide in humans is independent of endogenous GH-releasing hormone. Robinson BM; Friberg RD; Bowers CY; Barkan AL J Clin Endocrinol Metab; 1992 Oct; 75(4):1121-4. PubMed ID: 1400881 [TBL] [Abstract][Full Text] [Related]
17. Acipimox-mediated plasma free fatty acid depression per se stimulates growth hormone (GH) secretion in normal subjects and potentiates the response to other GH-releasing stimuli. Peino R; Cordido F; Peñalva A; Alvarez CV; Dieguez C; Casanueva FF J Clin Endocrinol Metab; 1996 Mar; 81(3):909-13. PubMed ID: 8772549 [TBL] [Abstract][Full Text] [Related]
18. Effects of muscarinic and adrenergic blockade on growth hormone secretion induced by growth hormone-releasing peptide-2 (GHRP-2) in ovariectomized ewes. Roh SG; Hirota M; He ML; Matsunaga N; Hidaka S; Hidari H Endocr J; 1997 Dec; 44(6):861-5. PubMed ID: 9622303 [TBL] [Abstract][Full Text] [Related]
19. Abuse of recombinant human growth hormone: studies in two different dog models. Rigamonti AE; Scanniffio D; Bonomo SM; Cella SG; Sartorio A; Müller EE Neuroendocrinology; 2004; 79(5):237-46. PubMed ID: 15218318 [TBL] [Abstract][Full Text] [Related]
20. Effect of growth hormone-releasing peptide 1-6 on GH secretion-stimulated by GHRH and pyridostigmine in lambs. Rico M; Rueda V; Lorenzo MT; Núñez A; De la Cruz LF J Physiol Biochem; 1998 Jun; 54(2):67-76. PubMed ID: 9858126 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]